Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ORIC Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of innovative cancer therapies. The firm focuses on overcoming treatment resistance through precision oncology medicines, aiming to significantly improve therapeutic outcomes for patients battling various cancers.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ORIC Pharmaceuticals is scheduled to report its next quarterly earnings on 11/09/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ORIC Pharmaceuticals last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at -0.38 USD.
ORIC Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.